1. Home
  2. TH vs MPLT Comparison

TH vs MPLT Comparison

Compare TH & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Target Hospitality Corp.

TH

Target Hospitality Corp.

N/A

Current Price

$19.52

Market Cap

1.8B

ML Signal

N/A

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$13.77

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TH
MPLT
Founded
1978
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2017
2025

Fundamental Metrics

Financial Performance
Metric
TH
MPLT
Price
$19.52
$13.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$16.50
$32.67
AVG Volume (30 Days)
1.2M
553.7K
Earning Date
05-18-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
82.39
EPS
N/A
N/A
Revenue
$320,635,000.00
N/A
Revenue This Year
$17.45
N/A
Revenue Next Year
$38.19
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.97
$9.10
52 Week High
$20.85
$40.43

Technical Indicators

Market Signals
Indicator
TH
MPLT
Relative Strength Index (RSI) 59.61 39.67
Support Level $15.49 $12.24
Resistance Level $18.83 $20.20
Average True Range (ATR) 0.96 0.94
MACD 0.14 0.89
Stochastic Oscillator 68.81 74.93

Price Performance

Historical Comparison
TH
MPLT

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services, including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. The company has three reportable segments: HFS - South, which provides specialty rental and hospitality services to the natural resources and development industry; WHS, which provides construction and hospitality solutions for critical mineral and data center projects; and Government, which provides specialty rental and hospitality services under government contracts.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: